A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma
Status:
Terminated
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out what effects (good and bad) the combination of the
chemotherapy drugs gemcitabine, capecitabine, and bevacizumab has on a patient and kidney
cancer.